Lastly, the loss of Arid2 promoted the expression of KLRD1 and inhibited TCF1 and TOX expression in the CXCR6+CD44+ cluster, further indicating an increased effector profile of tumor-specific CD8+ T cells following PBAF deletion (Figure 7J). The gene discussed is ARID2; the disease is neoplasm.